• Company
• The second CGRP migraine drug Ajovy's benefit is listed
• by Eo, Yun-Ho Oct 11, 2022 05:50am

• Company
• Only 2 out of 10 are prescribed monotherapy for diabetes
• by Kim, Jin-Gu Oct 7, 2022 06:04am

• Policy
• Two companies' Ticagrelor can be reimbursed
• by Lee, Tak-Sun Oct 7, 2022 06:04am

• Company
• Lilly prepares to introduce Olumiant for hair loss in Korea
• by Eo, Yun-Ho Oct 7, 2022 06:04am

• Company
• GC Pharma sells GSK's new shingles vaccine Shingrix together
• by Kim, Jin-Gu Oct 7, 2022 06:03am

• Policy
• Innovative pharmaceutical companies' new drug tx
• by Lee, Jeong-Hwan Oct 7, 2022 06:03am

• Policy
• The incidence of adverse effects in Alecensa is 80%
• by Lee, Hye-Kyung Oct 6, 2022 06:05am

• InterView
• “Sanofi’s flu vaccine is different...has 100-year legacy"
• by Oct 6, 2022 06:05am

• Policy
• MFDS prepares clinical trial guidelines for COVID-19 drugs
• by Lee, Hye-Kyung Oct 6, 2022 06:05am

• Company
• Daewoong Pharmaceutical launches botulinum drug in the UK
• by Chon, Seung-Hyun Oct 6, 2022 06:05am